新西兰药厂首席执行官Sarah Fitt在对更年期补丁供应问题的批评下辞职。 New Zealand's Pharmac CEO Sarah Fitt resigns amid criticism over menopause patch supply issues.

新西兰药房首席执行官Sarah Fitt将辞职7年,将于2025年5月30日生效。 Sarah Fitt, the Chief Executive of New Zealand's Pharmac for seven years, will resign effective May 30, 2025. Fitt的离开是在对药店处理更年期补丁供应问题的批评以及一份有10万签名的请愿书之后发生的。 Fitt's departure follows criticism over Pharmac's handling of menopause patch supply issues and a petition with 100,000 signatures. 副卫生部长David Seymour感谢Fitt为她提供了12年的服务,强调她致力于改善药品的获取。 Associate Health Minister David Seymour thanked Fitt for her 12 years of service, highlighting her commitment to improving access to medicines. 药剂师已开始寻找新的首席执行官。 Pharmac has initiated a search for a new CEO.